By Lisa Brown
Cataldo Leone, DMD, DMSc, GSDM Associate Dean for Academic Affairs and Professor, Periodontology and Molecular & Cell Biology, has been appointed as the Vice Chair of the Boston University Faculty Council, effective at the start of the 2017-2018 academic year.
Determined to communicate their message of inclusivity and support for science, nearly 100 of BUMC faculty, staff and students braved the rainy, chilly weather to carry colorful — and sometimes politically nuanced — signs as they marched toward Boston Common for the March for Science on Saturday afternoon.
Although their motivations for participating were varied, they all hoped to share positive messages about the impact science has on their lives and the need to have their voices heard.
Linda Hyman, PhD, associate provost of the Division of Graduate Medical Sciences, said she decided to march because it is important to communicate to the community at large that science is important, science saves lives and science is part of our everyday lives.
“What keeps me up at night is the training of the future leaders of the biomedical workforce,” Hyman said. “I am concerned that we are sending the message that science isn’t as important as it used to be.”
Ben Wolozin, MD, PhD, professor of pharmacology and experimental therapeutics, said he was inspired to participate in the March for Science in order to stand up for what he calls “evidence-based policy.”
“I don’t see how a company can run without addressing facts, I don’t see how you can plan your budget at home without addressing facts, and I don’t see how the government or Americans can address the future well without addressing facts,” he said.
Wolozin, whose research focuses on the causes of, and potential treatments for, neurodegenerative diseases such as Alzheimer’s or Parkinson’s, said funding cuts to the National Institutes of Health would have far-reaching effects.
“Just the threat of funding cuts to the National Institutes of Health has had an impact on science,” Wolozin said.
Jasmeet Hayes, PhD, assistant professor of psychiatry and research psychologist at the National Center for PTSD at the VA Boston Healthcare System, marched in order to speak up for military personnel and veterans.
“It is fundamentally important to support science,” Hayes said. “There are still a lot of treatments that don’t work for everybody, so we have to continue the scientific process and come up with the treatments that help as many people as we can.”
Hayes, whose research involves examining the effects of PTSD and Traumatic Brain Injury on the brain and cognition for military personnel and veterans, said she hoped marching would raise awareness that science can affect people on a personal, day-to-day level.
“The bottom line is if you support our veterans, you need to support science,” Hayes said.
PhD candidate Alicia Wooten was one of the featured speakers at the event. Wooten is deaf, and took the opportunity to discuss the importance of inclusivity in science.
“I didn’t need to hear a single thing to know that I could make a difference in science, despite other people’s doubt,” Wooten said. “It doesn’t matter what kind of disability you have, or the color of your skin or your gender. It is about what you can bring to the table. I am a scientist who just happens to be deaf.”
Brad Zehr, a fourth-year medical student, is concerned about the national dialogue surrounding science. He feels science is being disrespected on many levels. As a student looking forward to starting his residency, he said he could be especially impacted by potential funding cuts.
“Part of the responsibility of having the privilege of being so highly educated is to be very public about why we need to respect science and fund science,” he said. “Suddenly it’s very real to me when science is threatened because that is going to be my livelihood. We need to be the generation that stands up for science.”
See the Facebook album for more photos of the March.
The Provost’s Office is looking for candidates for the 2017 Medical Campus Emerging Leaders Program. The two-day workshop will be held on August 9 & 10 at BU’s Questrom School of Business (on the Charles River Campus) focuses on developing the leadership skills of some of our most promising junior faculty.
Sessions taught by faculty who teach in the health management MBA program will cover:
- Negotiating skills
- Leadership styles
- Financial decision making
Eligible faculty are:
- Late assistant professor or early associate professor with a full-time appointment at one of the three Medical Campus schools
- Willing to commit to attending both full days of leadership skills training
- Effective, innovative, reliable, and capable of mobilizing and energizing others
Interested? Please discuss this with your department chair or center director who should submit your name, CV, and a brief description of your promise as a leader (paragraph or two, no more than one page) by April 21 to email@example.com.
Chairs/Center Directors: Two, diverse candidates from each department preferred.
Candidates will be chosen on the strength of their promise as a leader, balance across schools and diversity of candidates’ backgrounds and expertise.
While preparing a manuscript for publication, one of an author’s chief concerns is plagiarism as even the accidental misuse of published material or the inclusion of insufficient citations can lead to serious consequences.
As a free service to authors on the Medical Campus, the Alumni Medical Library uses a program called TurnItIn to produce detailed Originality Reports, which flag each potential occurrence of plagiarism in the document along with providing an overall score indicating the possibility of plagiarism. The Librarians also provide context and commentary regarding these scores, as they can be a bit confusing to individuals unfamiliar with TurnItIn.
If you would like to make use of this service, please contact David Flynn.
Patriot’s Day will be celebrated on Monday, April 17.
Shuttle: No Daytime Service on Patriot’s Day for Boston University Shuttle. Late night service begins at 10 p.m.
MBTA: Commuter rail trains will operate on a regular weekday schedule. Buses will operate a weekday schedule. Some routes will be detoured at certain times during Marathon Monday to prevent disruption to the race or other Patriots’ Day events. For additional information on routes and schedules for Patriot’s Day, visit http://www.mbta.com/events/
Parking: All Parking facilities will be open. Employees should park in their assigned garages.
If you have any questions regarding this holiday schedule, please call the TranSComm Office of Transportation Services at 638-7473 or the Parking Office at 638-4915.
There are several spaces for meditation and prayer on the Medical Campus:
- Interfaith Chapel on the second floor of the East Newton Pavilion
- Temporary Chapel on the ground floor of the Dowling Building
- 7th Floor of the BioSpace at 650 Albany St., where the Muslim community congregates every Friday (Jummah Prayer) from 12:15-12:45 p.m.
- Muslim Dhur prayers Monday-Thursday in the Menino Temporary Chapel
The Medical Campus strives to create a culture and climate that demonstrates the belief that diversity adds value to intellectual development, academic discourse, patient care and research. We believe that diversity is essential to the development of future leaders in healthcare and research to serve our community, nation and world.
If you have any questions or concerns, please contact the BUSM Office of Diversity and Multicultural Affairs.
All students, faculty and staff from all BUMC schools are encouraged to submit artwork of any medium to the 27th annual Boston University Medical Campus gallery for the arts, sponsored by the Provost’s Office.
“Art Days” was begun by then Dean Chobanian to foster the support and growth of the creative arts at BUMC. It has been very successful and has shown work from students, faculty and staff and family members. The exhibition is mounted by the Creative Arts Society.
To be placed on the “submit list” or if you have any questions please contact: Keith Tornheim, PhD, at 638-8296
On March 31, the Creative Arts Society will accept paintings, photos, poetry, sculpture, needlework, etc. Pieces should be framed if possible. Security will be provided. Works will be returned April 5. Specific instructions will be sent at a later date to those who email Dr. Tornheim.
ART DAYS 2017
Monday-Tuesday, April 3-4
Instructional Building, Hiebert Lounge
Receptions both days at 3 p.m.
With strong bipartisan support for NIH funding, deep cuts unlikely to pass
During his election campaign, Donald Trump barely mentioned science, and what he did have to say about it—that climate change is a hoax, that he’d heard a lot about the National Institutes of Health (NIH) and it was terrible—was hardly encouraging to scientists. But despite low expectations, Trump’s 2018 budget blueprint, released last week, with sweeping cuts to medical research and public health programs (including $5.8 billion, or 18 percent, from the NIH), stunned researchers at Boston University and at research institutions across the country.
“The NIH cuts were what really caught people by surprise,” says Gloria Waters, vice president and associate provost for research. “Republicans have typically increased funding for the NIH. There was a lot of talk about how the NIH might even go up, as funding for other areas goes down, or ceases to exist. Funding for health research is typically a nonpartisan issue that all agree the government has got to be behind.”
“Like most scientists, I am terrified by the proposal,” says Neil Ganem, a School of Medicine assistant professor of pharmacology and experimental therapeutics, whose research in understanding how cells become cancerous opens up new avenues for treating cancer. A cut of nearly 20 percent to the NIH would be catastrophic, says Ganem.
“There would be fewer scientific breakthroughs, fewer clinical trials, less drug development. Citizens would suffer.”
However, he adds, he remains optimistic. “I truly believe that Congress will never let this budget proposal pass,” he says. “I think this budget will get blasted by many smart, responsible, and socially conscious politicians who understand the real value of science.”
Waters, and Jennifer Grodsky, vice president for federal relations, who closely tracks Congressional support for research funding as part of her job in advocating for BU faculty in Washington, agree that Ganem has a reason to be optimistic. “These cuts are unlikely to be enacted wholesale by Congress,” Grodsky wrote to administrators and faculty last week. “This is merely the first step in this year’s budget negotiations.”
“I truly believe that Congress will never let this budget proposal pass. I think this budget will get blasted by many smart, responsible, and socially conscious politicians who understand the real value of science.” —Neil Ganem
Trump’s budget blueprint is scant on details—it mentions no specific plans for the National Science Foundation (NSF), for example—and a more detailed proposal may be released as early as May, Grodsky says. (This budget, for fiscal year 2018, is separate from the current fiscal year 2017 budget, which remains in limbo until Congress completes work on its spending bills this spring.) There is strong bipartisan Congressional support for the NIH and medical research, she says, and it is unlikely that Trump’s deep cuts in those areas—part of the administration’s strategy for offsetting its proposed $54 billion increase in defense spending and paying to build a wall along the US-Mexico border—will be enacted.
Grodsky also believes that Trump’s proposed cuts to programs designed to make college more affordable, programs that have bipartisan support, are unlikely to come to fruition. The Trump blueprint eliminates Supplementary Education Opportunity Grants for low-income students, reduces the Federal Work-Study program significantly, and rescinds the $3.8 billion Pell Grant surplus. “Every Congressional office I visit puts college affordability and helping students at the top of their priority list,” says Grodsky. “I think legislators will reject any proposal that takes away resources for students in need.”
The funding priorities outlined in Trumps budget could have“direct impact on some of this country’s neediest college students,” says Christine McGuire, vice president ad interim for enrollment and student affairs, adding that BU students receive federal Pell Grants, Federal Supplemental Educational Opportunity Grants (commonly known as SEOG), and Federal Work-Study. “It is very early in the federal budget process,” she says. “But the University is concerned and is doing everything possible to mitigate the potential impact to our students.”
In fiscal year 2016, BU bucked the national trend of declining academic research funding and attracted $368.9 million in new research funding, an overall increase of 13 percent over the previous year. The federal government provided roughly $300 million—or nearly 82 percent—of that funding, with the biggest chunk coming from the NIH, which awarded BU faculty more than $200 million in grants, more than two thirds of the overall money.
“The thing we’ve said over and over is that the federal government is the largest funder of science,” Waters says.“Its not like there is anything in the wings that is going to replace that. Some people think industry can play a role, and we’re trying to increase our relationships with industry, but there is no way that is going to replace funding from the federal government. Some people think the university can pay for research, but we don’t have the funds to replace the money the federal government has put into research.”
Waters’ office is helping BU faculty increase their research funding by streamlining the grant application and fulfillment process and helping scientists form partnerships with industry and navigate the dizzyingly complex funding world of Washington. One way her office intends to respond to the budget blueprint, Waters says, is to intensify its efforts to aid faculty in securing research money.
Still, as she acknowledges, the budget blueprint can be viewed as a statement about Trump’s view of science, and researchers at BU and elsewhere have expressed fears that the blueprint threatens not just their work to improve human health, but the work of future generations of academic scientists.
“The proposed cuts to NIH research will significantly slow the pace of discovery,” says Daniel Remick, a MED professor of pathology and laboratory medicine. “The initiatives to understand and treat so many diseases—cancer, diabetes, substance abuse, Alzheimer’s disease—have just been told to slow down or stop.”
With reductions to federal funding in the past decade, it is already tough enough for Ganem and other researchers to win the grants that keep their labs afloat. Trump’s budget blueprint threatens “to make success as an academic researcher even more difficult to attain,” says Catherine Klapperich, a College of Engineering professor of biomedical engineering and director of the Center for Future Technologies in Cancer Care. “It sends a message to young scientists that we do not value their work.”
Sandro Galea, Robert S. Knox Professor and dean of the School of Public Health, worries that “the biggest hit of this budget could be the reduction of opportunities for the next generation of public health scientists, who will see their options curtailed, and who may choose to take their talents to other industries.” He says that “we would face a lost generation from which it would take us decades to recover.”
For more than 20 years now, Boston has received the most NIH funding of any US city, according to the Boston Planning and Development Agency. In 2015, 41 Boston institutions, including the BU Medical Campus, received more than $1.74 billion in NIH funding—or nearly 70 percent of all NIH funding to Massachusetts entities. “Any proposed cuts to NIH funding are not only bad for our local economy here in Massachusetts, but more important, would have devastating impacts for patients across the world,” says Bob Coughlin, president and chief executive officer of the Massachusetts Biotechnology Council. “Growth in research is what leads us to breakthrough therapies and much-needed cures for patients.”
“The NIH cuts were what really caught people by surprise… Funding for health research is typically a nonpartisan issue that all agree the government has got to be behind.” —Gloria Waters
If the deep cuts to NIH become a reality, Ganem says, “it would mean that hospitals, medical schools, and universities would immediately institute hiring freezes. Consequently, postdocs, unable to find academic jobs, would start accumulating and be forced into alternative career paths, many, I’m sure, outside of science. Jobs would be lost. The reality is that if principal investigators don’t get grants, then they don’t hire technicians, laboratory staff, and students; they also don’t buy reagents or services from local companies. There is a real trickle-down economic effect.”
In addition to the deep cuts to the NIH, the administration has also called for a reduction of $900 million, or 17 percent, to the Department of Energy’s Office of Science, and it would eliminate the Advanced Research Projects Agency-Energy, which develops energy technologies that are too early in the development phase for private sector investment.
The Trump administration has also proposed increasing funding for the National Aeronautics and Space Administration’s Planetary Science to $1.9 billion, or about 16 percent, while cutting its Earth Science program by $102 million, or about 5 percent.
“These are all proposed budget cuts, so until people’s funding gets taken away or entire programs actually get cut, we won’t know who or what projects will be affected,” says Pamela Templer, a College of Arts & Sciences professor of biology, whose research focuses on the impact of environmental change. “We’re all currently focused on the uncertainty.”
However, Templer adds, if the proposed budget were to be approved by Congress, it “would have a devastating effect on many aspects of science throughout the United States, with big hits on the environment and health. Clean water and air are not partisan issues. Maintaining a healthy environment benefits all Americans.”
For humanities scholars, who have been contending with threatened cuts in federal funding for many years, the budget blueprint brings yet more bad news. Trump has proposed eliminating the National Endowment for the Humanities (NEH), an independent federal agency that was created in 1965 and is one of the largest funders of humanities programs in the country, as well as eliminating the National Endowment for the Arts (NEA).
“The NEH and NEA are crucial for supporting not only the scholarly or creative work of faculty in higher education, especially at BU,” says Gene A. Jarrett, CAS associate dean of the faculty, humanities, and a professor of English and African American studies, “but they also fund the programming outside of our academic walls, such as public libraries and museums, which advance the early education of children and the civic education of people living in our communities. Slashing the support of these endowments would undercut the robust educational apparatus, with its attention to the diverse and free expression of ideas, that has distinguished our civic society since the Congressional creation of these endowments in 1965.”
But Grodsky says she is skeptical that the NEH and NEA will be eliminated. “These are important cultural agencies, with strong champions on both sides of the aisle in Congress,” she says. “Democrats and Republicans have both already expressed concerns about the proposal.”
In the wake of the Trump election, she says, more BU faculty have begun expressing strong interest in becoming involved in advocacy efforts. “When scholars stand up for their research on Capitol Hill,” she says, “we know it makes a difference.”
This BU Today story was written by Sara Rimer.
Faculty cited for contributions to science, medicine, public health
Osteoarthritis causes chronic pain for hundreds of millions of people around the world, an estimated 30 million in the United States alone. Doctors can help with medication to treat pain for this most common form of arthritis, and can recommend physical therapy and joint replacement surgery when needed. But, says Tuhina Neogi, a recently promoted School of Medicine professor of medicine, that pretty much covers the treatment options currently available—and that limited toolset is what drives her research into the causes of, and cures for, osteoarthritis (OA).
“A lot of the recent work I have been doing is to understand the pain mechanisms in osteoarthritis,” says Neogi, former chairwoman of the US Food and Drug Administration’s Arthritis Advisory Committee. She is currently conducting a large longitudinal study funded by the National Institutes of Health (NIH) to evaluate patients’ experience with pain and correlated alterations in their nervous systems. “People with OA can develop chronic pain, even at rest,” she says. “By understanding these nervous system alterations, we can gain insight into new treatment targets.”
That insight could also lead to better recommendations for the timing of knee replacement surgery by taking a patient’s nervous system changes into account to reduce the risk of an unsuccessful procedure. It’s just one of several inquiries led by Neogi, who joined the MED faculty as a research fellow in 2003, and whose work also includes significant findings about the triggers for gout that has led to new treatment recommendations (including avoiding consumption of wine).
Neogi is one of 11 MED faculty members promoted to full professor. Three School of Public Health faculty have been promoted to full professor as well.
“We congratulate our very accomplished recently promoted professors,” says Karen Antman, dean of MED and provost of the Medical Campus. “These senior leaders have made significant contributions to science and medicine, and are nationally and internationally recognized as experts in their disciplines.”
Sandro Galea, Robert A. Knox Professor and dean of SPH, says the promotions of SPH faculty Matthew Fox, Jack Clark, and Michael McClean “reflect the deep well of talent and experience each of these faculty members brings to the school. We are delighted to have professors McClean, Fox, and Clark in our midst. Their work moves the needle forward in important areas, globally and locally. I look forward to their continuing contributions to BU and the field of public health.”
Matthew Fox (SPH’02,’07), a professor of epidemiology and global health, is an infectious disease expert. He is codirector of the Health Economics and Epidemiology Research Office (HE2RO), a collaboration between BU public health researchers and researchers from South Africa’s University of Witwatersrand. In his work at HE2RO, a project operated by BU’s Center for Global Health and Development, Fox analyzes treatment data to find solutions to bettering HIV treatment, broadening treatment access, and improving outcomes for the least cost. His team’s work provides South Africa policymakers with information to improve the lives of more than three million people being treated for HIV. The World Health Organization has formulated treatment protocols based in part on Fox’s work. He is the primary investigator or coinvestigator on grants from the World Bank, the Bill and Melinda Gates Foundation, the NIH, and USAID/South Africa.
Fox has cowritten a book on his data-driven research methods, Applying Quantitative Bias Analysis to Epidemiologic Data.
“It’s incredibly gratifying and exciting to be working on problems that require big solutions and that require rigorous evaluation, problems that affect millions of people,” says Fox, adding that the data analysis involved calls for creativity in the search for real-world solutions. “That makes it both fun and useful.”
Also promoted to professor on the Medical Campus are:
Daniel Alford (SPH’86, MED’92), School of Medicine professor of medicine
Alford, assistant dean for continuing medical education, is an expert in addiction medicine and safe opioid prescribing for pain. He developed and directs the Safe and Competent Opioid Prescribing Education (SCOPE) program, which has trained more than 34,000 clinicians in the United States to safely and effectively manage patients suffering from chronic pain with opioid analgesics. For the past 15 years, he has also directed the Chief Resident Immersion Training in Addiction Medicine program, funded by the National Institute on Drug Abuse, which has trained more than 390 faculty from 117 residency training programs. Alford has received numerous teaching and service awards, from the American Medical Association and the White House Office of National Drug Control Policy, among others.
Stephan Anderson, MED professor of radiology
Anderson, an in-vivo and in-vitro imaging expert, has created collaborations with mechanical engineering and micro/nanotechnology experts to develop new imaging technologies. In addition, he has developed and validated imaging techniques for the study of diffuse liver disease and trauma. He is section chief of body imaging and is a primary investigator or coinvestigator on grants supported by the National Science Foundation, the NIH, GE Healthcare, and Philips Healthcare.
Tarik Haydar, MED professor of anatomy and neurobiology
On the faculty since 2010, Haydar is known for his pioneering research in brain development in Down syndrome and for his research explaining how neural progenitors generate the variety of neurons within the developing neocortex. His publications include invited editorials and critical reviews in Science, Cell, Neuron, Nature Neuroscience and other journals. Haydar has served on several dozen NIH review committees and recently chaired the Neural Cell Fate NIH Study Section. He is primary investigator on four active grants.
Robin Ingalls, MED professor of medicine
The work of Ingalls, an infectious diseases expert who has been at MED since 1995, has been critical in advancing the understanding of diseases such as sepsis, pelvic inflammatory disease, and pneumonia. Ingalls is known for collaborating with basic scientists to develop innovative, clinically relevant research, and her expertise extends to innate immunity, sexually transmitted diseases, and bacterial pathogenesis. She serves on the NIH Immunity and Host Defense study section and the Veterans Affairs Infectious Disease Merit panel.
Virginia R. Litle, MED professor of surgery
Litle is an expert in the management of chest malignancies, esophageal cancer in particular, and in reducing the perioperative risk of venous thromboembolism. She directs several programs at Boston Medical Center, including the Barrett’s Esophagus Program, the Clinical Research Program in Thoracic Surgery, and the Center for Minimally Invasive Esophageal Therapies. Litle has participated in multi-institutional research groups since 2005, and was principal investigator on an NIH-funded translational research project of microRNA profiling of Barrett’s esophagus and esophageal cancer.
Jennifer I. Luebke (MED’90), MED professor of anatomy and neurobiology
Luebke, anatomy and neurobiology department vice chair and graduate program director, is an expert on the structure and function of neurons in the cerebral cortex. Her research focuses on the normal structure and function of individual cortical pyramidal cells and their alterations in transgenic mouse models of neurological disease and in a rhesus monkey model of normal aging. The director of MED’s Laboratory of Cellular Neurobiology, Luebke has published papers and review articles focusing on the effects of normal aging and the morphology of cortical neurons.
David McAneny, MED professor of surgery
Recognized for his work on cost-effective and safe management of surgical patients, McAneny and his team developed a mnemonic device for simple interventions to reduce pulmonary complications after surgery, such as pneumonia. Called I COUGH, it has been adopted by scores of hospitals in the United States and other English-speaking countries. McAneny’s expertise is in endocrine surgery and hepatobiliary-pancreas-gastrointestinal surgery. He is a recipient of MED’s annual Stanley L. Robbins Award for Excellence in Teaching, given in recognition of a faculty member’s teaching and devotion to students.
Michael Paasche-Orlow, MED professor of medicine
Paasche-Orlow, a leader in the emerging field of health literacy, has coordinated statewide learning networks for health providers in New Hampshire, Kentucky, and Minnesota, and has helped create and evaluate a range of patient empowerment and decision-support tools. He is the founding editor in chief of the new journal Health Literacy Research and Practice and has run the international Health Literacy Annual Research Conference, the largest such conference, for the past eight years.
Marie-Helene Saint-Hilaire, MED professor of neurology
An expert on movement disorders, Saint-Hilaire is a leading researcher of Parkinson’s disease. Her research interests include new medications and the role of neurorehabilitation and neuroprotective treatments and the search for biomarkers in Parkinson’s. She directs MED’s Parkinson’s Disease and Movement Disorders Center, where she focuses on clinical research in Parkinson’s and Huntington’s diseases. Since 2003, Saint-Hilaire has directed the American Parkinson Disease Association Advanced Center for Parkinson Research, one of eight such US centers. Her research has been funded by the NIH, the Michael J. Fox Foundation for Parkinson’s Research, the American Parkinson Disease Association, and industry.
Flora Sam, MED professor of medicine
Cardiologist Sam is recognized worldwide as an expert in a type of heart failure called preserved ejection fraction, also known as diastolic heart failure. Her outstanding scholarly achievement in biomedical research was recognized by election to the American Society for Clinical Investigation in 2011. Sam’s translational research program, supported by the NIH, investigates inter-tissue communication in heart failure. Her research has contributed to defining important biomarkers in cardiac amyloidosis, a disorder that disrupts the proper working of the heart.
Jack Clark, School of Public Health professor of health law, policy, and management
Clark is an internationally known medical sociologist and health scientist whose research focuses on how people live with chronic diseases, use health services, communicate with doctors, reach treatment decisions, and perceive health care outcomes. He developed the concept of regret in patients following their decisions about the type of care they receive, first defined in studies to characterize the outcomes of prostate cancer treatment. Clark developed patient-centered tools to assess care outcomes and led studies to improve the quality of care provided in the Veterans Health Administration. His current research projects are funded by VA Health Services Research & Development, the VHA Office of Rural Health, and the American Cancer Society.
Michael McClean, SPH professor of environmental health
McClean, SPH associate dean for research and faculty advancement, is a scholar in environmental and occupational exposure assessment. His studies of potential health effects from exposures to chemical, physical, or biological agents have resulted in more than 130 peer-reviewed articles in such journals as Environmental Health Perspectives, Journal of Occupational and Environmental Medicine, and Neurology. McClean has applied his exposure assessment method to a range of public health issues, including kidney disease, occupational cancer, and most recently, traumatic brain injuries.
This BU Today article was written by Michael Goldberg. He can be reached at firstname.lastname@example.org.
BU Medical Campus Schedule for Tuesday, March 14:
BUSM GMS classes will be canceled. Employees in essential services should report as scheduled. Medical, PA and GMS students who are assigned to inpatient services are expected to be present, if possible. Students who are assigned to outpatient services should check with their course director or the policy at the clinical site. Non-essential staff may telecommute.
The Henry M. Goldman School of Dental Medicine will follow normal school hours. All Patient Treatment Centers will be open for patient care and all classes will be held as scheduled, unless notified by the Office of Academic Affairs. GSDM students who are on externship, should check with the policy at their respective externship site.
BU School of Public Health classes are canceled; SPH non-essential staff may telecommute at the discretion of their supervisor.
A City of Boston snow emergency has been declared as of 7 a.m. Tuesday. Please consider public transportation, if available, for travel to the medical campus to reduce traffic on the roadways. Employees who are part of the BUMC parking program should park in your assigned lot or garage.